Menopause May Leave a Molecular Signature Linked to Brain Aging

Key Takeaways

• Researchers identified a set of 16 blood proteins whose levels shifted across the menopausal transition, independent of chronological age.

• The proteins were connected to inflammation, synaptic activity, metabolism, and other pathways relevant to brain aging.

• A composite “menopause protein score” rose across stages of the transition and was associated with later cognitive outcomes in analyses of four independent cohorts.

• The findings are observational: they do not show that menopause causes later cognitive decline or that the protein score can predict any one person’s future.

More Than a Reproductive Transition

Menopause is a normal life transition, but its biology extends far beyond the reproductive system. Changes in hormone levels, immune signaling, metabolism, and brain function may occur during this period, making midlife an important window for studying how women’s brains age.

The new work focused on proteins in blood serum—molecules that can offer a broad snapshot of biological activity. The researchers initially compared 30 premenopausal, 26 perimenopausal, and 24 postmenopausal women ages 43 to 58, with 36 age-matched men included for comparison.

After accounting for age, they found 16 proteins that were higher after menopause. These proteins were linked mainly to inflammatory activity, alongside pathways involved in synapses and metabolism.

Building a Molecular Score

Rather than interpreting each protein in isolation, the researchers combined the 16 signals into a single proteomic score intended to reflect menopause-related biology. The score was higher in perimenopausal participants than premenopausal participants and higher still after menopause.

Importantly, the shift appeared to track menopausal stage more strongly than calendar age. That distinction suggests the protein changes may reflect a specific biological transition rather than simply getting older year by year.

The discovery sample was small, so the team then tested the protein pattern in nearly 3,000 women from the UK Biobank. Of the 13 proteins available in both datasets, nine showed the same menopause-stage pattern.

Links to Later Cognition

The researchers next examined whether the composite score related to later-life cognitive outcomes. Across four independent cohorts of older women, higher baseline scores—reflecting a more postmenopausal protein pattern—were associated with poorer cognitive health later in life.

That association is scientifically interesting, but it is not a diagnosis or a forecast for an individual. Many factors influence cognitive aging, including education, cardiovascular and metabolic health, sleep, physical activity, genetics, social conditions, and access to care. The study does not establish which of the measured proteins are drivers of brain aging and which are simply markers of other changes.

Hormones and Immune Signals

The protein score was positively associated with follicle-stimulating hormone and inversely associated with estradiol, fitting the major hormonal shifts of the menopausal transition. Some individual proteins tied to inflammation were also inversely related to estradiol, consistent with the idea that hormonal and immune changes may interact.

The researchers found less consistent evidence linking the score to vasomotor symptoms such as hot flashes and night sweats. That uncertainty is a reminder that menopause is biologically diverse: symptoms, hormone patterns, and long-term health trajectories vary widely among individuals.

What This Could Enable

The study does not offer a new test or intervention. Its contribution is a research framework: a way to study a measurable midlife protein pattern that may connect reproductive aging with later brain health.

Future studies will need to determine whether these signals change over time within the same people, whether they improve risk prediction beyond established factors, and whether any modifiable intervention can alter the relevant biology. For now, the work supports a more nuanced view of menopause—as a meaningful transition for brain-aging research, not as an inevitable path toward cognitive decline.

References:

Wood Alexander M, et al. Blood proteomics of menopause map to brain aging. Nature Medicine (2026). DOI: 10.1038/s41591-026-04648-4.